Medical Research and Biotechnology Committee

Internal: to keep members up-to-date on cutting-edge developments in the law relevant to medical research and the use of nanobiotech and biotechnology in clinical practice;
External: to partake in activities that meaningfully contribute to the development of sound laws, policies and regulations governing biomedical research and clinical practice; and
Networking: to provide members with an opportunity to network with colleagues on the committee and with relevant external organizations and individuals.

Comments on U.S. FDA Guidance entitled “Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs) January 2015
Franken-Food or Scare Tactics? The Science, Law and Technology of Genetically Modified Foods – Excerpts from Panel Discussion NYSBA Health Law Journal Spring/Summer 2015
NYSBA Health Law Section Medical Research and Biotechnology Committee and Food, Drug Cosmetic Law Section Recommended Changes to Accommodate Biosimilars – November 2015
Health Law Section Medical Research and Biotechnology Committee: Proposed Revisions To The Common Rule Federal Policy For The Protection of Human Subjects – October 26, 2015
NYSBA Health Law Section Medical Research and Biotechnology Committee and Food, Drug Cosmetic Law Section Comments on FDA Guidance on “Nonproprietary Naming of Biological Products: Guidance for Industry” October 26, 2015